国产两女互慰高潮视频在线观看,无码人妻精品一二三区免费,亚洲av无码av制服另类专区,欧美一区二区三区成人片在线

首頁 > 產品目錄 > 信號通路 > Immunology & Inflammation > COX(Cyclooxygenase) > 依托考昔

依托考昔

ChemLeader 98+%

Etoricoxib (MK-663; MK-0663)

產品編號:CL1843 CAS No.:202409-33-4 MDLNo: 分子式:C18H15ClN2O2S 分子量:358.84
規格 庫存 目錄價 會員專享價 數量
25 mg 3-5days ¥400.00 登錄后可見
- +
50 mg 3-5days ¥650.00 登錄后可見
- +
100 mg 3-5days ¥850.00 登錄后可見
- +

化學品安全說明書(MSDS)

下載MSDS
  • 基本信息
  • 相關文檔
  • 產品詳情
  • 相關文獻
基本信息
英文名稱 Etoricoxib (MK-663; MK-0663)
中文名稱依托考昔
CAS號202409-33-4
分子式C18H15ClN2O2S
分子量358.84
外觀Light yellow to yellow powder
儲存條件 Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
產品詳情

Etoricoxib (also known as MK-0663) is a non-steroidal anti-inflammatory drgu (NSAID) which acts as a selective and orally bioactive COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood. Etoricoxib is a synthetic NSAID with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib binds specifically to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.

相關文獻
抱歉,暫時沒有相關文獻
相關產品
抱歉,暫時沒有相關產品
在線客服
小德
021-58180488
小立
021-58180488
在線服務時間: 工作日 9:00-18:00